210 related articles for article (PubMed ID: 20042251)
1. Enzymatic glycosylation, inhibitor design, and synthesis and formation of glyco-self assembled monolayers for simulation of recognition.
Scheppokat AM; Gerber A; Schroven A; Meinke S; Kopitzki S; Beketow E; Thimm J; Thiem J
Eur J Cell Biol; 2010 Jan; 89(1):39-52. PubMed ID: 20042251
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
3. Preparation of sialylated oligosaccharides employing recombinant trans-sialidase from Trypanosoma cruzi.
Neubacher B; Schmidt D; Ziegelmuller P; Thiem J
Org Biomol Chem; 2005 Apr; 3(8):1551-6. PubMed ID: 15827656
[TBL] [Abstract][Full Text] [Related]
4. A sialidase mutant displaying trans-sialidase activity.
Paris G; Ratier L; Amaya MF; Nguyen T; Alzari PM; Frasch AC
J Mol Biol; 2005 Jan; 345(4):923-34. PubMed ID: 15588836
[TBL] [Abstract][Full Text] [Related]
5. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the O-linked pentasaccharide in glycoproteins of Trypanosoma cruzi and selective sialylation by recombinant trans-sialidase.
Mendoza VM; Agusti R; Gallo-Rodriguez C; de Lederkremer RM
Carbohydr Res; 2006 Jul; 341(10):1488-97. PubMed ID: 16630598
[TBL] [Abstract][Full Text] [Related]
7. Comparative rates of sialylation by recombinant trans-sialidase and inhibitor properties of synthetic oligosaccharides from Trypanosoma cruzi mucins-containing galactofuranose and galactopyranose.
Agustí R; Giorgi ME; Mendoza VM; Gallo-Rodriguez C; de Lederkremer RM
Bioorg Med Chem; 2007 Apr; 15(7):2611-6. PubMed ID: 17292612
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic sialylation of N-linked oligosaccharides using an alpha-(2,3)-specific trans-sialidase from Trypanosoma cruzi: structural identification using a three-dimensional elution mapping technique.
Takahashi N; Lee KB; Nakagawa H; Tsukamoto Y; Kawamura Y; Li YT; Lee YC
Anal Biochem; 1995 Sep; 230(2):333-42. PubMed ID: 7503427
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
[TBL] [Abstract][Full Text] [Related]
11. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
12. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
13. The trans-sialidase from Trypanosoma cruzi efficiently transfers alpha-(2-->3)-linked N-glycolylneuraminic acid to terminal beta-galactosyl units.
Agustí R; Giorgi ME; de Lederkremer RM
Carbohydr Res; 2007 Nov; 342(16):2465-9. PubMed ID: 17765882
[TBL] [Abstract][Full Text] [Related]
14. NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi.
Haselhorst T; Wilson JC; Liakatos A; Kiefel MJ; Dyason JC; von Itzstein M
Glycobiology; 2004 Oct; 14(10):895-907. PubMed ID: 15190004
[TBL] [Abstract][Full Text] [Related]
15. Transsialidase from Trypanosoma cruzi for regio- and stereoselective synthesis of N-acyl-modified sialylated oligosaccharides and measurement of transfer rates.
Schroven A; Meinke S; Ziegelmüller P; Thiem J
Chemistry; 2007; 13(32):9012-21. PubMed ID: 17680570
[TBL] [Abstract][Full Text] [Related]
16. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
17. Transfer of modified sialic acids by Trypanosoma cruzi trans-sialidase for attachment of functional groups to oligosaccharide.
Lee KB; Lee YC
Anal Biochem; 1994 Feb; 216(2):358-64. PubMed ID: 8179190
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic modeling of the oligosaccharide chains of glycoproteins immobilized onto polystyrene surfaces.
Orberger G; Gessner R; Fuchs H; Volz B; Köttgen E; Tauber R
Anal Biochem; 1993 Oct; 214(1):195-204. PubMed ID: 7504410
[TBL] [Abstract][Full Text] [Related]
19. Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry.
Meinke S; Thiem J
Top Curr Chem; 2015; 367():231-50. PubMed ID: 22648866
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
